My Account
Equity
Sustainable Investing

Emerging Markets Inflection Points

Analyzing macro trends and transition investing opportunities shaping emerging markets in 2026.

08/21/2026

Key Takeaways

Transition investing can identify emerging markets (EM) companies adapting to sustainability-related business shifts.

Clean mobility, energy efficiency and resource management may support revenue growth, cost reduction and operational resilience.

Torrent Pharmaceuticals highlights how transition efforts may help lower costs, strengthen operations and support competitiveness.

How Are Transition Trends Creating Opportunities in Emerging Markets?

As we discussed in the previous issue of Emerging Markets Inflection Points, sustainability, economic growth and the potential for competitive returns form the core of our Emerging Market Transition strategy. Through this lens, we look for EM companies that are entering new markets, generating new revenue streams, reducing costs or enhancing efficiencies as they become more sustainable.

For example, some emerging markets are playing an increasingly important role in clean mobility and are driving the global electric vehicle (EV) boom. Automotive companies in China, Brazil and Indonesia are seeing significant revenue growth by capturing domestic EV market share and accelerating EV exports to other countries.

Examples of how EM companies are benefiting from transition-related strategies include:

As a reminder, we consider a wide range of EM companies that fit this framework. Some are in the early stages of their transition-related efforts, while others are experienced first-movers. We also believe that companies pursue and benefit from sustainability efforts that go beyond a singular focus on reducing carbon emissions.

What Can Torrent Pharmaceuticals Tell Us About EM Transition Efforts?

Torrent Pharmaceuticals, an India-based firm that manufactures branded generics, exemplifies an EM company employing a transition strategy designed to boost business growth by lowering costs and emphasizing increased sustainability within the pharmaceutical industry.

Torrent has accelerated its sustainability efforts, as evidenced, in part, by its significantly improved sustainability disclosures. This increased transparency reflects the company’s focus on growth and environmental stewardship.

Most notably, Torrent has reduced its Scope 1 and 2 emissions by 32% relative to its fiscal year (FY) 2019-2020 baseline and has set an even more ambitious goal of a 70% reduction by FY 2029-2030.1 Torrent’s progress reflects initiatives to expand renewable energy use, switch to lower-emission fuels and improve manufacturing efficiency. Together, these actions may help lower operating costs, reduce exposure to energy price volatility and strengthen operational resilience.

Torrent is also making progress in resource efficiency, achieving year-over-year reductions in water withdrawals and consumption. Its waste management performance remains particularly strong, with 98% of total waste diverted from landfills. The company recycles 100% of its nonhazardous waste, and 75% of its operational sites are now classified as zero-waste-to-landfill.2

These accomplishments are significant outcomes for a resource-intensive industry in which water availability, waste management and environmental compliance can directly affect production and profitability.

At the same time, Torrent continues to target areas for improvement, including Scope 3 emissions. Reporting in this area remains incomplete, and the company’s emissions intensity increased modestly. However, Torrent is working toward a 10% reduction in Scope 3 emissions intensity by FY 2029-2030 – significantly expanding its transition strategy beyond its own operations and into its supply chain.3

In our view, Torrent’s improving sustainability performance complements the company’s other perceived strengths, including manufacturing quality, cost optimization, regulatory readiness and operational efficiency.

As sustainability becomes more deeply embedded in Torrent’s business model, we believe this will help increase the company’s long-term competitiveness and resilience.

Authors
Sarah Bratton Hughes
Sarah Bratton Hughes

Head of Sustainable Investing

Curious About EM Opportunities?

Learn more about transition investing in emerging markets.

1

Torrent Pharmaceuticals Ltd., “Building Core Strength, Unlocking Future Potential,” Integrated Annual Report 2025–26, released May 29, 2026.

2

Ibid.

3

Ibid.

References to specific securities are for illustrative purposes only and are not intended as recommendations to purchase or sell securities. Opinions and estimates offered constitute our judgment and, along with other portfolio data, are subject to change without notice.

The opinions expressed are those of American Century Investments (or the portfolio manager) and are no guarantee of the future performance of any American Century Investments portfolio. This material has been prepared for educational purposes only. It is not intended to provide, and should not be relied upon for, investment, accounting, legal or tax advice.

The portfolio managers use a variety of analytical research tools and techniques to help them make decisions about buying or holding issuers that meet their investment criteria and selling issuers that do not. In addition to fundamental financial metrics, the portfolio managers may also consider environmental, social, and/or governance (ESG) data to evaluate an issuer's sustainability characteristics. However, the portfolio managers may not consider ESG data with respect to every investment decision and, even when such data is considered, they may conclude that other attributes of an investment outweigh sustainability-related considerations when making decisions. Sustainability-related characteristics may or may not impact the performance of an issuer or the strategy, and the strategy may perform differently if it did not consider ESG data. Issuers with strong sustainability-related characteristics may or may not outperform issuers with weak sustainability-related characteristics. ESG data used by the portfolio managers often lacks standardization, consistency, and transparency, and may not be available, complete, or accurate. Not all American Century investment strategies incorporate ESG data into the process.